SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GPSite who wrote (62)7/6/1999 8:06:00 AM
From: EmuGreg  Read Replies (1) of 250
 
GP-Do you have any sense as to how frequently announcements might come from a company involved in a double-blind Phase III study? I've been following a company developing a laser treatment for hyperopia for the past 3 years. From that experience, I have a sense as to what kind of news releases that they might issue...but the double-blind factor is not a part of the equation. Do you think there could be much VXGN news before the end of the Phase III trials and the submission of the PMA request?

Thanks.
Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext